Evidence map›Paper›PMID 30108699›Full record

ArticleMedChemComm2017

Synthesis and biological evaluation of memantine nitrates as a potential treatment for neurodegenerative diseases.

Zheng Liu, Si Yang, Xiaoyong Jin, Gaoxiao Zhang, Baojian Guo, Haiyun Chen, Pei Yu, Yewei Sun, Zaijun Zhang, Yuqiang Wang

Open access · bronzeAbstract read
In one paragraph

Article in MedChemComm, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Zheng LiuInstitute of New Drug Research and Guangzhou Key Laboratory of Innovative Chemical Drug Research in Cardio-cerebrovascular Diseases , Jinan University College of Pharmacy , Guangzhou , 510632 , China . Email: yxy0723@163.com ; Email: zaijunzhang@163.com ; ; Tel: +86 20 8522 5030.
Si YangInstitute of New Drug Research and Guangzhou Key Laboratory of Innovative Chemical Drug Research in Cardio-cerebrovascular Diseases , Jinan University College of Pharmacy , Guangzhou , 510632 , China . Email: yxy0723@163.com ; Email: zaijunzhang@163.com ; ; Tel: +86 20 8522 5030.
Xiaoyong JinInstitute of New Drug Research and Guangzhou Key Laboratory of Innovative Chemical Drug Research in Cardio-cerebrovascular Diseases , Jinan University College of Pharmacy , Guangzhou , 510632 , China . Email: yxy0723@163.com ; Email: zaijunzhang@163.com ; ; Tel: +86 20 8522 5030.
Gaoxiao ZhangInstitute of New Drug Research and Guangzhou Key Laboratory of Innovative Chemical Drug Research in Cardio-cerebrovascular Diseases , Jinan University College of Pharmacy , Guangzhou , 510632 , China . Email: yxy0723@163.com ; Email: zaijunzhang@163.com ; ; Tel: +86 20 8522 5030.
Baojian GuoInstitute of New Drug Research and Guangzhou Key Laboratory of Innovative Chemical Drug Research in Cardio-cerebrovascular Diseases , Jinan University College of Pharmacy , Guangzhou , 510632 , China . Email: yxy0723@163.com ; Email: zaijunzhang@163.com ; ; Tel: +86 20 8522 5030.
Haiyun ChenInstitute of New Drug Research and Guangzhou Key Laboratory of Innovative Chemical Drug Research in Cardio-cerebrovascular Diseases , Jinan University College of Pharmacy , Guangzhou , 510632 , China . Email: yxy0723@163.com ; Email: zaijunzhang@163.com ; ; Tel: +86 20 8522 5030.
Pei YuInstitute of New Drug Research and Guangzhou Key Laboratory of Innovative Chemical Drug Research in Cardio-cerebrovascular Diseases , Jinan University College of Pharmacy , Guangzhou , 510632 , China . Email: yxy0723@163.com ; Email: zaijunzhang@163.com ; ; Tel: +86 20 8522 5030.
Yewei SunInstitute of New Drug Research and Guangzhou Key Laboratory of Innovative Chemical Drug Research in Cardio-cerebrovascular Diseases , Jinan University College of Pharmacy , Guangzhou , 510632 , China . Email: yxy0723@163.com ; Email: zaijunzhang@163.com ; ; Tel: +86 20 8522 5030.
Zaijun ZhangInstitute of New Drug Research and Guangzhou Key Laboratory of Innovative Chemical Drug Research in Cardio-cerebrovascular Diseases , Jinan University College of Pharmacy , Guangzhou , 510632 , China . Email: yxy0723@163.com ; Email: zaijunzhang@163.com ; ; Tel: +86 20 8522 5030.
Yuqiang WangInstitute of New Drug Research and Guangzhou Key Laboratory of Innovative Chemical Drug Research in Cardio-cerebrovascular Diseases , Jinan University College of Pharmacy , Guangzhou , 510632 , China . Email: yxy0723@163.com ; Email: zaijunzhang@163.com ; ; Tel: +86 20 8522 5030.
Jinan University · LBJinan University · CNGuangdong Institute for Drug Control · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A series of memantine nitrate derivatives, as dual functional compounds with neuroprotective and vasodilatory activity for neurodegenerative diseases, was designed and synthesized. These compounds combined the memantine skeleton and a nitrate moiety, and thus inhibited the

Identifiers

PMID30108699
PMCPMC6072337
OpenAlexW2537243286

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.